Central serotonin depletion: effect on blood pressure during anesthesia

Area of Science:

• Neuroscience
• Cardiovascular Physiology
• Pharmacology

Background:

• Central nervous system serotonin (5-HT) influences blood pressure in normotensive and hypertensive states.
• Parachlorophenylalanine (PCPA) is used to deplete central 5-HT.
• Understanding 5-HT's role in cardiovascular control under anesthesia is crucial.

Purpose of the Study:

• To investigate the role of central serotonin in cardiovascular regulation during enflurane anesthesia.
• To compare the effects of serotonin depletion in normotensive Wistar rats, renal artery-clipped hypertensive rats (RHR), and spontaneously hypertensive rats (SHR).

Main Methods:

• Central serotonin depletion using PCPA in Wistar rats, RHR, and SHR.
• Measurement of mean arterial blood pressure (MAP), heart rate (HR), and plasma norepinephrine (NE).
• Assessment under awake conditions, enflurane anesthesia, and enflurane anesthesia with saralasin administration.

Main Results:

• PCPA effectively depleted central serotonin by over 70% without altering brain catecholamines.
• In Wistar rats and RHR, PCPA treatment led to significantly higher MAP, HR, and plasma NE during enflurane anesthesia (with or without saralasin) compared to controls.
• SHR showed no significant differences in MAP, HR, or plasma NE between PCPA-treated and vehicle-treated groups under anesthesia.

Conclusions:

• Central serotonin plays a significant role in cardiovascular control during enflurane anesthesia in Wistar rats and RHR.
• This role appears diminished or absent in spontaneously hypertensive rats (SHR).
• Findings highlight differential mechanisms of cardiovascular regulation in various hypertensive models.